Global Antibodies Contract Manufacturing Market Analysis Report 2022: Monoclonal Antibodies, Polyclonal Antibodies, Others – Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antibodies Contract Manufacturing Market Size, Share & Trends Analysis Report, by Product (Monoclonal Antibodies, Polyclonal Antibodies, Others), by Source, by End Use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global antibodies contract manufacturing market is expected to reach USD 35.9 billion by 2030, registering a CAGR … [Read more…]

LifeWorks purchases buy-in annuity contracts for Stelco’s Hamilton Works

Secures benefit entitlements of all plan participants; involves two Canadian insurers TORONTO–(BUSINESS WIRE)–LifeWorks, in its capacity as plan administrator, has purchased buy-in annuity contracts on May 31, 2022 for the Stelco Inc. Retirement Plan for USW Local 1005 Members at Hamilton Works (the “plan”) in order to secure the benefit entitlements of all plan participants. … [Read more…]

Gene Therapy Global Market Research Report 2022 by Gene Type (Antigen; Cytokine; Suicide Gene; Others) & Vector (Viral Vector; Non-Viral Vector) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gene Therapy Global Market Report 2022: By Gene, By Vector, By Application, By End-User” report has been added to ResearchAndMarkets.com’s offering. The global gene therapy market is expected to grow from $5.77 billion in 2021 to $7.37 billion in 2022 at a compound annual growth rate (CAGR) of 27.8%. The growth is mainly … [Read more…]

Insights on the Renal Biomarkers Global Market to 2027 – by Biomarker Type, Diagnostic Technique, End-user and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global renal biomarkers market reached a value of US$ 1.13 billion in 2021. Looking forward, the market is projected to reach a value of US$ 1.88 billion by 2027, exhibiting a CAGR … [Read more…]

Global Metabolomics Market Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F by Product & Service, Application, Indication, Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Metabolomics Global Market Report 2022, By Product & Service, By Application, By Indication, By Metabolomics Instruments, By Metabolomics Bioinformatics Tools & Services” report has been added to ResearchAndMarkets.com’s offering. The global metabolomics market is expected to grow from $2.35 billion in 2021 to $2.69 billion in 2022 at a compound annual growth rate … [Read more…]

Microbiome Global (FMT, Microbiome Drugs) Market Report 2022 Featuring Major Players – MicroBiome Therapeutics; Seres Therapeutics; Enterome Bioscience; Second Genome; Vedanta Biosciences – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Microbiome Global Market Report 2022: By Type, By Application, By Technology” report has been added to ResearchAndMarkets.com’s offering. The global microbiome market is expected to grow from $5.54 billion in 2021 to $6.18 billion in 2022 at a compound annual growth rate (CAGR) of 11.4%. The market is expected to reach $10.09 billion … [Read more…]

OneSpaWorld to Present at the Jefferies Consumer Conference

NEW YORK–(BUSINESS WIRE)–OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, will hold a virtual fireside chat presentation at the Jefferies Consumer Conference. The fireside chat presentation will be available on Monday, June 20, 2022 beginning at … [Read more…]

JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company

Company advancing ZB-168, an anti-IL7Rα monoclonal antibody, originally developed by Pfizer Inc., in multiple phase 2 clinical trials The transaction values the combined companies at a pro forma enterprise value of $215 million Total gross proceeds of up to $189 million of which up to $139 million is from the cash held in trust (assuming … [Read more…]

The AmerisourceBergen Foundation Commits $150,000 to Equitable Vaccination Efforts Across the Globe

Funding will support the United Nations Foundation’s Shot@Life, a grassroots advocacy campaign that champions global immunization CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, has committed $150,000 to the United Nations Foundation’s Shot@Life campaign to support vaccine equity, protecting the world’s most … [Read more…]

Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)

–          Sizable and sustained improvement in Hammersmith Functional Motor Scale-Expanded (HFMSE) scores observed at 24 months –          Substantial increase in Revised Upper Limb Module (RULM) scores observed at 24 months –          No serious safety risks identified over 24 months –          Enrollment progressing in pivotal Phase 3 SAPPHIRE registrational trial –          Scholar Rock to host webcast today … [Read more…]